{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T08:07:15Z","timestamp":1791619635252,"version":"4.3.4"},"reference-count":175,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>The bile acid pool with its individual bile acids (BA) is modulated in the enterohepatic circulation by the liver as the primary site of synthesis, the motility of the gallbladder and of the intestinal tract, as well as by bacterial enzymes in the intestine. The nuclear receptor farnesoid X receptor (FXR) and Gpbar1 (TGR5) are important set screws in this process. Bile acids have a vasodilatory effect, at least according to <jats:italic>in vitro<\/jats:italic> studies. The present review examines the question of the extent to which the increase in bile acids in plasma could be responsible for the hyperdynamic circulatory disturbance of liver cirrhosis and whether modulation of the bile acid pool, for example, <jats:italic>via<\/jats:italic> administration of ursodeoxycholic acid (UDCA) or <jats:italic>via<\/jats:italic> modulation of the dysbiosis present in liver cirrhosis could influence the hemodynamic disorder of liver cirrhosis. According to our analysis, the evidence for this is limited. Long-term studies on this question are lacking.<\/jats:p>","DOI":"10.3389\/fphys.2021.718783","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T11:14:31Z","timestamp":1627557271000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction"],"prefix":"10.3389","volume":"12","author":[{"given":"Tilman","family":"Sauerbruch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hennenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"G459","DOI":"10.1152\/ajpgi.1995.268.3.G459","article-title":"Enhanced endothelium-dependent vasodilation in patients with cirrhosis","volume":"268","author":"Albillos","year":"1995","journal-title":"Am. J. Phys."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1172\/JCI110668","article-title":"Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum","volume":"70","author":"Angelin","year":"1982","journal-title":"J. Clin. Invest."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12072-017-9798-x","article-title":"Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg","volume":"12","author":"Arab","year":"2018","journal-title":"Hepatol. Int."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/ACO.0000000000000963","article-title":"Pathophysiology of sepsis","volume":"34","author":"Arina","year":"2021","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","article-title":"The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis","volume":"74","author":"Arroyo","year":"2021","journal-title":"J. Hepatol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1440-1746.1996.tb00064.x","article-title":"Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease","volume":"11","author":"Azer","year":"1996","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/apt.13435","article-title":"Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis","volume":"43","author":"Bajaj","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/hep.29791","article-title":"Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort","volume":"68","author":"Bajaj","year":"2018","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1053\/j.gastro.2020.07.019","article-title":"Serum levels of metabolites produced by intestinal microbes and lipid moieties independently associated with acute-on-chronic liver failure and death in patients with cirrhosis","volume":"159","author":"Bajaj","year":"2020","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1111\/j.1572-0241.1999.01450.x","article-title":"A pilot study on the hemodynamic effect of short-term ursodeoxycholic acid therapy in patients with stable liver cirrhosis","volume":"94","author":"Baruch","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0168-8278(97)80012-8","article-title":"Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins","volume":"26","author":"Battista","year":"1997","journal-title":"J. Hepatol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.femsre.2004.09.003","article-title":"The interaction between bacteria and bile","volume":"29","author":"Begley","year":"2005","journal-title":"FEMS Microbiol. Rev."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/cld.141","article-title":"Cirrhotic cardiomyopathy","volume":"2","author":"Bernardi","year":"2013","journal-title":"Clin. Liver Dis. (Hoboken)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/gutjnl-2019-318843","article-title":"Albumin in decompensated cirrhosis: new concepts and perspectives","volume":"69","author":"Bernardi","year":"2020","journal-title":"Gut"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/hep.1840150409","article-title":"Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease","volume":"15","author":"Beuers","year":"1992","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J. Hepatol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/014107689608901204","article-title":"Nitric oxide 9 years on","volume":"89","author":"Bhagat","year":"1996","journal-title":"J. R. Soc. Med."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1478-3231.2008.01664.x","article-title":"Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension","volume":"28","author":"Biecker","year":"2008","journal-title":"Liver Int."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0163-7258(01)00124-3","article-title":"The hyperdynamic circulation in cirrhosis: an overview","volume":"89","author":"Blendis","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.bbrc.2016.07.047","article-title":"Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice","volume":"478","author":"Bode","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0006-2952(94)00428-O","article-title":"Bile acids as endogenous vasodilators?","volume":"49","author":"Bomzon","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/0016-5085(80)90197-3","article-title":"Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis","volume":"78","author":"Bosch","year":"1980","journal-title":"Gastroenterology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jhep.2018.03.031","article-title":"Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis","volume":"69","author":"Brandl","year":"2018","journal-title":"J. Hepatol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/BF01308099","article-title":"Sulfated bile acids in serum, bile, and urine of cirrhotic patients before and after portacaval anastomosis","volume":"26","author":"Capocaccia","year":"1981","journal-title":"Dig. Dis. Sci."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31708","article-title":"The use of Rifaximin in patients with cirrhosis","author":"Caraceni","year":"2021","journal-title":"Hepatology"},{"key":"ref27","first-page":"719","volume-title":"Enterohepatic Circulation.","author":"Carey","year":"1994"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/S0022-2275(20)35729-1","article-title":"Comparative binding of bile acids to serum lipoproteins and albumin","volume":"34","author":"Ceryak","year":"1993","journal-title":"J. Lipid Res."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41385-019-0162-4","article-title":"Emerging roles of bile acids in mucosal immunity and inflammation","volume":"12","author":"Chen","year":"2019","journal-title":"Mucosal Immunol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","article-title":"Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis","volume":"58","author":"Chen","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/cld.861","article-title":"Bile acid biology, pathophysiology, and therapeutics","volume":"15","author":"Chiang","year":"2020","journal-title":"Clin. Liver. Dis. (Hoboken)"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/apt.14949","article-title":"Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis","volume":"48","author":"Ciocan","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/liv.13306","article-title":"Management of cholestatic disease in 2017","volume":"37","author":"de Vries","year":"2017","journal-title":"Liver Int."},{"key":"ref34","volume-title":"From Bacteria to BACH and Back: The Evolution of Minds.","author":"Dennett","year":"2017"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/hep.28890","article-title":"Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart","volume":"65","author":"Desai","year":"2017","journal-title":"Hepatology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.bbadis.2017.08.021","article-title":"Bile acid receptors in the biliary tree: TGR5 in physiology and disease","volume":"1864","author":"Deutschmann","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1053\/j.gastro.2014.08.031","article-title":"Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial","volume":"147","author":"Dhiman","year":"2014","journal-title":"Gastroenterology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000462974","article-title":"Molecular mechanisms leading to splanchnic vasodilation in liver cirrhosis","volume":"54","author":"Di Pascoli","year":"2017","journal-title":"J. Vasc. Res."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jhep.2012.02.014","article-title":"Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health","volume":"57","author":"Dilger","year":"2012","journal-title":"J. Hepatol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1085\/jgp.20028537","article-title":"Natural bile acids and synthetic analogues modulate large conductance Ca2+-activated K+ (BKCa) channel activity in smooth muscle cells","volume":"119","author":"Dopico","year":"2002","journal-title":"J. Gen. Physiol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.dld.2013.10.021","article-title":"The bile acid TGR5 membrane receptor: from basic research to clinical application","volume":"46","author":"Duboc","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"100220","DOI":"10.1016\/j.jhepr.2020.100220","article-title":"Gut dysbiosis as a driver in alcohol-induced liver injury","volume":"3","author":"Fairfield","year":"2021","journal-title":"JHEP Rep."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/gut.2005.076562","article-title":"Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites","volume":"55","author":"Ferguson","year":"2006","journal-title":"Gut"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cgh.2019.07.055","article-title":"Efficacy of albumin treatment for patients with cirrhosis and infections unrelated to spontaneous bacterial peritonitis","volume":"18","author":"Fernandez","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis","volume":"157","author":"Fernandez","year":"2019","journal-title":"Gastroenterology"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","article-title":"Biliary bile acids in hepatobiliary injury- what is the link?","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"101094","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.1038\/ncomms8715","article-title":"Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery","volume":"6","author":"Flynn","year":"2015","journal-title":"Nat. Commun."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1124\/jpet.113.210005","article-title":"G protein-coupled bile acid receptor 1 stimulation mediates arterial vasodilation through a K(Ca)1.1 (BK(Ca))-dependent mechanism","volume":"348","author":"Fryer","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"G21","DOI":"10.1152\/ajpgi.1990.259.1.G21","article-title":"Bile acids do not mediate the hyperdynamic circulation in portal hypertensive rats","volume":"259","author":"Genecin","year":"1990","journal-title":"Am. J. Phys."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/j.cgh.2015.04.024","article-title":"The art and science of diagnosing and treating lung and heart disease secondary to liver disease","volume":"13","author":"Goldberg","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"83951","DOI":"10.18632\/oncotarget.13796","article-title":"Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis","volume":"7","author":"Gong","year":"2016","journal-title":"Oncotarget"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1053\/j.gastro.2013.06.036","article-title":"Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis","volume":"145","author":"Grace","year":"2013","journal-title":"Gastroenterology"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.niox.2019.10.008","article-title":"Modulation of endothelium-derived nitric oxide production and activity by taurine and taurine-conjugated bile acids","volume":"94","author":"Guizoni","year":"2020","journal-title":"Nitric Oxide"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fphys.2016.00646","article-title":"TGR5, not only a metabolic regulator","volume":"7","author":"Guo","year":"","journal-title":"Front. Physiol."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"","journal-title":"Immunity"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"935","DOI":"10.14309\/ajg.0000000000001197","article-title":"Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta-analysis","volume":"116","author":"Gurusamy","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1053\/j.gastro.2020.09.060","article-title":"Aging, frailty, and the microbiome-how dysbiosis influences human aging and disease","volume":"160","author":"Haran","year":"2021","journal-title":"Gastroenterology"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/01.RES.0000200400.55539.85","article-title":"Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells","volume":"98","author":"He","year":"2006","journal-title":"Circ. Res."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/00365529950173726","article-title":"Nitrite and nitrate levels in patients with cirrhosis of the liver: influence of kidney function and fasting state","volume":"34","author":"Heller","year":"","journal-title":"Scand. J. Gastroenterol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/s0016-5085(99)70136-8","article-title":"Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis","volume":"116","author":"Heller","year":"","journal-title":"Gastroenterology"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1478-3231.2005.01053.x","article-title":"Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis","volume":"25","author":"Heller","year":"2005","journal-title":"Liver Int."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0016-5085(00)70263-0","article-title":"Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis","volume":"118","author":"Helmy","year":"2000","journal-title":"Gastroenterology"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0168-8278(02)00319-7","article-title":"Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis","volume":"38","author":"Helmy","year":"2003","journal-title":"J. Hepatol."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1053\/j.gastro.2005.11.029","article-title":"Defective RhoA\/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats","volume":"130","author":"Hennenberg","year":"2006","journal-title":"Gastroenterology"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/hep.21502","article-title":"Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins","volume":"45","author":"Hennenberg","year":"2007","journal-title":"Hepatology"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/j.1478-3231.2009.02010.x","article-title":"Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: result of unchanged vascular Rho-kinase?","volume":"29","author":"Hennenberg","year":"","journal-title":"Liver Int."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/j.1365-2362.2009.02181.x","article-title":"Vascular hyporesponsiveness to angiotensin II in rats with CCl(4)-induced liver cirrhosis","volume":"39","author":"Hennenberg","year":"","journal-title":"Eur. J. Clin. Investig."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/gut.2007.144584","article-title":"Mechanisms of extrahepatic vasodilation in portal hypertension","volume":"57","author":"Hennenberg","year":"2008","journal-title":"Gut"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1136\/gut.25.10.1034","article-title":"Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis","volume":"25","author":"Henriksen","year":"1984","journal-title":"Gut"},{"key":"ref72","first-page":"677","article-title":"Bile Acids","volume-title":"The Liver: Biology and Pathobiology.","author":"Hofmann","year":"1994"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/hep.22789","article-title":"Bile acids: trying to understand their chemistry and biology with the hope of helping patients","volume":"49","author":"Hofmann","year":"2009","journal-title":"Hepatology"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1194\/jlr.R049437","article-title":"Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades","volume":"55","author":"Hofmann","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0016-5085(19)32574-0","article-title":"Effect of portacaval shunt and arterialization of the liver on bile acid metabolism","volume":"69","author":"Horak","year":"1975","journal-title":"Gastroenterology"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/liv.13201","article-title":"Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis","volume":"37","author":"Horvatits","year":"","journal-title":"Liver Int."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1055\/s-0042-121268","article-title":"Serum bile acids in patients with hepatopulmonary syndrome","volume":"55","author":"Horvatits","year":"","journal-title":"Z. Gastroenterol."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1053\/j.gastro.2008.07.019","article-title":"Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment","volume":"135","author":"Huet","year":"2008","journal-title":"Gastroenterology"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2007.02.006","article-title":"Vascular endothelial dysfunction in cirrhosis","volume":"46","author":"Iwakiri","year":"2007","journal-title":"J. Hepatol."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","article-title":"Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions","volume":"61","author":"Iwakiri","year":"2014","journal-title":"J. Hepatol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.taap.2018.04.012","article-title":"Deoxycholylglycine, a conjugated secondary bile acid, reduces vascular tone by attenuating Ca(2+) sensitivity via rho kinase pathway","volume":"348","author":"Jadeja","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1038\/ctg.2016.44","article-title":"Rifaximin exerts beneficial effects independent of its ability to alter microbiota composition","volume":"7","author":"Kang","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/hep.21458","article-title":"The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells","volume":"45","author":"Keitel","year":"2007","journal-title":"Hepatology"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejphar.2005.05.037","article-title":"Deoxycholyltaurine-induced vasodilation of rodent aorta is nitric oxide- and muscarinic M(3) receptor-dependent","volume":"517","author":"Khurana","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1161\/ATVBAHA.113.301565","article-title":"Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells","volume":"33","author":"Kida","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/hep.28898","article-title":"Rifaximin has no effect on hemodynamics in decompensated cirrhosis: a randomized, double-blind, placebo-controlled trial","volume":"65","author":"Kimer","year":"2017","journal-title":"Hepatology"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/jgh.13852","article-title":"Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: a randomized trial","volume":"33","author":"Kimer","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/biom9060232","article-title":"The biosynthesis, signaling, and neurological functions of bile acids","volume":"9","author":"Kiriyama","year":"2019","journal-title":"Biomol. Ther."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000371670","article-title":"Bile acids as hormones: the FXR-FGF15\/19 pathway","volume":"33","author":"Kliewer","year":"2015","journal-title":"Dig. Dis."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1432-1033.1979.tb06257.x","article-title":"Bile salt binding to serum components. Taurocholate incorporation into high-density lipoprotein revealed by photoaffinity labelling","volume":"102","author":"Kramer","year":"1979","journal-title":"Eur. J. Biochem."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJM197410032911401","article-title":"Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption","volume":"291","author":"LaRusso","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jcmgh.2021.01.011","article-title":"Circulating bile acids in liver failure activate TGR5 and induce monocyte dysfunction","volume":"12","author":"Leonhardt","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1111\/bph.15172","article-title":"Regulation of smooth muscle contraction by monomeric non-RhoA GTPases","volume":"177","author":"Li","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/cvr\/cvm016","article-title":"FXR-mediated regulation of eNOS expression in vascular endothelial cells","volume":"77","author":"Li","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12876-018-0842-7","article-title":"Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments","volume":"18","author":"Liu","year":"2018","journal-title":"BMC Gastroenterol."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.bjp.0703554","article-title":"On the in vitro vasoactivity of bile acids","volume":"131","author":"Ljubuncic","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/hep.1840060110","article-title":"Prognostic significance of serum bile acids in cirrhosis","volume":"6","author":"Mannes","year":"1986","journal-title":"Hepatology"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/hep.1840200411","article-title":"Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index","volume":"20","author":"Maroto","year":"1994","journal-title":"Hepatology"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.dld.2020.06.048","article-title":"Effect of poorly absorbable antibiotics on hepatic venous pressure gradient in cirrhosis: A systematic review and meta-analysis","volume":"52","author":"Mendoza","year":"2020","journal-title":"Dig. Liver Dis."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1136\/gut.2010.226407","article-title":"Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction","volume":"60","author":"Moleda","year":"2011","journal-title":"Gut"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0168-8278(98)80353-X","article-title":"Neurally-mediated vasodilatation in normal and portal hypertensive rats: role of nitric oxide and calcitonin gene-related peptide","volume":"28","author":"Moll-Kaufmann","year":"1998","journal-title":"J. Hepatol."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1136\/gut.2010.235473","article-title":"Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis","volume":"60","author":"Moller","year":"2011","journal-title":"Gut"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/gutjnl-2019-320170","article-title":"Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation","volume":"70","author":"Monteiro","year":"2021","journal-title":"Gut"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/sj.bjp.0703471","article-title":"Bile acids increase intracellular Ca(2+) concentration and nitric oxide production in vascular endothelial cells","volume":"130","author":"Nakajima","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1046\/j.1365-2362.2003.01131.x","article-title":"Portal hypertension is associated with increased mRNA levels of vasopressor G-protein-coupled receptors in human hepatic arteries","volume":"33","author":"Neef","year":"2003","journal-title":"Eur. J. Clin. Investig."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000078153","article-title":"Effect of intraduodenal administration of ursodeoxycholic acid on interdigestive interaction between gallbladder motility, pancreatic secretion and endocrine activity","volume":"69","author":"Neubrand","year":"2004","journal-title":"Digestion"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0016-5085(84)80022-0","article-title":"Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis","volume":"86","author":"Ohkubo","year":"1984","journal-title":"Gastroenterology"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/j.1476-5381.1994.tb13212.x","article-title":"Mechanism of bile salt vasoactivity: dependence on calcium channels in vascular smooth muscle","volume":"112","author":"Pak","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"ref114","first-page":"1175","article-title":"Vasoactive effects of bile salts in cirrhotic rats: in vivo and in vitro studies","volume":"18","author":"Pak","year":"1993","journal-title":"Hepatology"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1053\/jhep.2003.50118","article-title":"A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice","volume":"37","author":"Pelletier","year":"2003","journal-title":"Hepatology"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/0016-5085(81)90253-5","article-title":"Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size","volume":"80","author":"Ponz de Leon","year":"1981","journal-title":"Gastroenterology"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.3748\/wjg.v23.i25.4491","article-title":"Eubiotic properties of rifaximin: disruption of the traditional concepts in gut microbiota modulation","volume":"23","author":"Ponziani","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1159\/000360516","article-title":"Evidence-based treatment of primary biliary cirrhosis","volume":"32","author":"Poupon","year":"2014","journal-title":"Dig. Dis."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1365-2362.1976.tb00522.x","article-title":"Influence of bile acids upon biliary cholesterol and phospholipid secretion in the dog","volume":"6","author":"Poupon","year":"1976","journal-title":"Eur. J. Clin. Investig."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/hep.1840170412","article-title":"Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy","volume":"17","author":"Poupon","year":"1993","journal-title":"Hepatology"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/liv.14433","article-title":"Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure","volume":"40","author":"Praktiknjo","year":"","journal-title":"Liver Int."},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322621","article-title":"Hepatic inflammasome activation as origin of interleukin-1alpha and interleukin-1beta in liver cirrhosis","author":"Praktiknjo","year":"","journal-title":"Gut"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/eurheartj\/ehs011","article-title":"Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia\/reperfusion injury","volume":"34","author":"Pu","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1136\/heartjnl-2013-304163","article-title":"Bile acids induce arrhythmias in human atrial myocardium--implications for altered serum bile acid composition in patients with atrial fibrillation","volume":"99","author":"Rainer","year":"2013","journal-title":"Heart"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"186","DOI":"10.7326\/0003-4819-139-3-200308050-00008","article-title":"The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial","volume":"139","author":"Rasaratnam","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"192","DOI":"10.14218\/JCTH.2016.00023","article-title":"Ursodeoxycholic acid in treatment of non-cholestatic liver diseases: a systematic review","volume":"4","author":"Reardon","year":"2016","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000371678","article-title":"Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut","volume":"33","author":"Ridlon","year":"2015","journal-title":"Dig. Dis."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S0022-2275(20)38147-5","article-title":"Quantitative aspects of the interaction of bile acids with human serum albumin","volume":"23","author":"Roda","year":"1982","journal-title":"J. Lipid Res."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0022-2275(20)42614-8","article-title":"Bile acid structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol\/water partition coefficient and reverse phase HPLC","volume":"31","author":"Roda","year":"1990","journal-title":"J. Lipid Res."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1172\/JCI103451","article-title":"Bile acid content of human serum. II. The binding of cholanic acids by human plasma proteins","volume":"36","author":"Rudman","year":"1957","journal-title":"J. Clin. Invest."},{"key":"ref132","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3109\/00365529609006774","article-title":"Acute effect of ursodeoxycholic acid on gallbladder volume in healthy subjects","volume":"31","author":"Sailer","year":"1996","journal-title":"Scand. J. Gastroenterol."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jhep.2018.10.019","article-title":"Microbiome as a therapeutic target in alcohol-related liver disease","volume":"70","author":"Sarin","year":"2019","journal-title":"J. Hepatol."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/gut.19.11.1006","article-title":"Diurnal serum levels of primary conjugated bile acids. Assessment by specific radioimmunoassays for conjugates of cholic and chenodeoxycholic acid","volume":"19","author":"Schalm","year":"1978","journal-title":"Gut"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/jhep.2001.28794","article-title":"Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: evidence for a receptor-specific mechanism","volume":"34","author":"Schepke","year":"","journal-title":"Hepatology"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/gast.2001.26295","article-title":"Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension","volume":"121","author":"Schepke","year":"","journal-title":"Gastroenterology"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000007742","article-title":"Effects of ursodeoxycholic acid on splanchnic and systemic hemodynamics. A double-blind, cross-over, placebo-controlled study in healthy volunteers","volume":"61","author":"Schiedermaier","year":"2000","journal-title":"Digestion"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jhep.2016.12.005","article-title":"The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction","volume":"66","author":"Schwabl","year":"2017","journal-title":"J. Hepatol."},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.04.013","article-title":"Impact of antibiotic resistance genes in gut microbiome of patients with cirrhosis","author":"Shamsaddini","year":"2021","journal-title":"Gastroenterology"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1053\/j.gastro.2018.01.028","article-title":"Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis","volume":"154","author":"Simon-Talero","year":"2018","journal-title":"Gastroenterology"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1046\/j.1365-2125.1999.00940.x","article-title":"Ursodeoxycholic acid and endothelial-dependent, nitric oxide-independent vasodilatation of forearm resistance arteries in patients with coronary heart disease","volume":"47","author":"Sinisalo","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000375344","article-title":"Challenges and management of liver cirrhosis: pathophysiology of renal dysfunction in cirrhosis","volume":"33","author":"Sola","year":"2015","journal-title":"Dig. Dis."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/cvr\/cvy023","article-title":"Vascular smooth muscle contraction in hypertension","volume":"114","author":"Touyz","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref146","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fimmu.2019.00476","article-title":"Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis","volume":"10","author":"Trebicka","year":"2019","journal-title":"Front. Immunol."},{"key":"ref147","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41575-020-00376-3","article-title":"Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure","volume":"18","author":"Trebicka","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref148","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/hep.21673","article-title":"Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/Rho-kinase and activation of endothelial nitric oxide synthase","volume":"46","author":"Trebicka","year":"2007","journal-title":"Hepatology"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/MEG.0b013e32834a75dc","article-title":"Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt","volume":"23","author":"Trebicka","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/nu12010047","article-title":"Associations between dietary patterns and bile acids-results from a cross-sectional study in vegans and omnivores","volume":"12","author":"Trefflich","year":"2019","journal-title":"Nutrients"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11901-020-00521-1","article-title":"Hemodynamic and systemic effects of albumin in patients with advanced liver disease","author":"Tufoni","year":"2020","journal-title":"Curr. Hepatol. Rep."},{"key":"ref152","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/S0140-6736(96)09424-X","article-title":"Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?","volume":"349","author":"Vallance","year":"1997","journal-title":"Lancet"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.bbadis.2017.12.039","article-title":"Heart and bile acids - clinical consequences of altered bile acid metabolism","volume":"1864","author":"Vasavan","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"ref154","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/hep.26939","article-title":"Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats","volume":"59","author":"Verbeke","year":"2014","journal-title":"Hepatology"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajpath.2014.10.009","article-title":"The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats","volume":"185","author":"Verbeke","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref156","doi-asserted-by":"publisher","first-page":"33453","DOI":"10.1038\/srep33453","article-title":"FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis","volume":"6","author":"Verbeke","year":"2016","journal-title":"Sci. Rep."},{"key":"ref157","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/j.1365-2036.2009.03958.x","article-title":"Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis","volume":"29","author":"Vlachogiannakos","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref158","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/jgh.12070","article-title":"Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis","volume":"28","author":"Vlachogiannakos","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref159","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/hep.1840010210","article-title":"Bile acid metabolism in cirrhosis. VII. Evidence for defective feedback control of bile acid synthesis","volume":"1","author":"Vlahcevic","year":"1981","journal-title":"Hepatology"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/liv.13394","article-title":"Bile acids and cardiovascular function in cirrhosis","volume":"37","author":"Voiosu","year":"2017","journal-title":"Liver Int."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jacc.2011.10.880","article-title":"Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial","volume":"59","author":"von Haehling","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref162","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jcmgh.2020.02.005","article-title":"A physiology-based model of bile acid distribution and metabolism under healthy and pathologic conditions in human beings","volume":"10","author":"Voronova","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref163","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1042\/CS20160501","article-title":"Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load","volume":"130","author":"Walsh","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1021\/acs.jproteome.5b00217","article-title":"Serum bile acids are associated with pathological progression of hepatitis B-induced cirrhosis","volume":"15","author":"Wang","year":"2016","journal-title":"J. Proteome Res."},{"key":"ref165","doi-asserted-by":"publisher","first-page":"619039","DOI":"10.3389\/fimmu.2020.619039","article-title":"Characterization of blood immune cells in patients with decompensated cirrhosis including ACLF","volume":"11","author":"Weiss","year":"2020","journal-title":"Front. Immunol."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1172\/JCI7458","article-title":"Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility","volume":"104","author":"Wiest","year":"","journal-title":"J. Clin. Invest."},{"key":"ref167","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1053\/jhep.2002.31432","article-title":"The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough","volume":"35","author":"Wiest","year":"2002","journal-title":"Hepatology"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"G1043","DOI":"10.1152\/ajpgi.1999.276.4.G1043","article-title":"NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats","volume":"276","author":"Wiest","year":"","journal-title":"Am. J. Phys."},{"key":"ref169","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1042\/CS19980275","article-title":"Effects of ursodeoxycholic acid on systemic, renal and forearm haemodynamics and sodium homoeostasis in cirrhotic patients with refractory ascites","volume":"96","author":"Wong","year":"1999","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.08.025","article-title":"Progression of stage 2 and 3 acute kidney injury in patients with decompensated cirrhosis and ascites","author":"Wong","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref171","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1172\/JCI90562","article-title":"Intestinal fungi contribute to development of alcoholic liver disease","volume":"127","author":"Yang","year":"2017","journal-title":"J. Clin. Invest."},{"key":"ref172","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1042\/CS20080075","article-title":"Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis","volume":"116","author":"Yang","year":"2009","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12012-010-9069-8","article-title":"The role of lipophilic bile acids in the development of cirrhotic cardiomyopathy","volume":"10","author":"Zavecz","year":"2010","journal-title":"Cardiovasc. Toxicol."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/1440-1681.12535","article-title":"Farnesoid X receptor regulates vasoreactivity via angiotensin II type 2 receptor and the kallikrein-kinin system in vascular endothelial cells","volume":"43","author":"Zhang","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1096\/fj.201902496RR","article-title":"TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA\/ROCK signaling","volume":"34","author":"Zhu","year":"2020","journal-title":"FASEB J."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.718783\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T11:14:37Z","timestamp":1627557277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.718783\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":175,"alternative-id":["10.3389\/fphys.2021.718783"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.718783","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,29]]},"article-number":"718783"}}